The following is a link to December 2005 R&D Day of MEDX. Though now 9 months later, it will suffice to elucidate what the company is doing. Slide 37 of the Lonberg presentation shows the preclinical results of anti-CTLA4 alone, anti-PD-1 alone, and the combination:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.